- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05908565
Project 2: Optimizing Engagement and Outcomes in STAND Digital Therapy (P2)
July 29, 2025 updated by: Michelle Craske, University of California, Los Angeles
The goal is to optimize peer coaching in order to optimize engagement and outcomes in digital therapy.
The unmet mental health needs of community college students are staggering and a growing body of research demonstrates that therapy provided digitally with the assistance of trained community members without advanced degrees in mental health is an effective and scalable way to address these needs.
Despite being effective for improving symptoms and functioning in those who engage in it, uptake and engagement in digital therapy is generally quite low.
Recent research suggests that this is especially true of Latinx individuals, who tend to have unique and significant unmet mental health needs.
To address these issues, Project 2 will examine treatment engagement, treatment satisfaction, symptoms and functioning outcomes among Latinx students at East Los Angeles College (ELAC) receiving digital therapy with peer coaching in the STAND program.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
A sample of 240 students who identify as Latinx will be recruited.
A 2x2 design will randomize students to 1 of 4 peer coaching conditions (n = 60 per condition): 1) demographic matching + standard supervision, 2) demographic matching + reduced supervision, 3) no demographic matching + standard supervision, and 4) no demographic matching + reduced supervision.
Students in the demographic matching condition will be assigned to peer coaches who also identify as Latinx, whereas those in the no demographic matching condition will be assigned to peer coaches who do not identify as Latinx.
Supervision will either involve individual session review and personalized feedback or not.
Students will participate in this project for 24 weeks and will complete brief weekly assessment batteries and longer assessment batteries at baseline and at weeks 8, 16 and 24.
Explanatory/intervening variables that are hypothesized to explain treatment effects will also be explored.
In addition to the quantitative data collected from the randomized controlled trial, we will collect and analyze qualitative data from the peer coaches via annual focus groups and will evaluate cost-effectiveness specifically focused on costs related to supervision.
These data will inform the iterative refinements made to Tier II in the Signature Project.
Study Type
Interventional
Enrollment (Estimated)
240
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tamar Kodish, Ph.D.
- Email: tamarkodish@ucla.edu
Study Contact Backup
- Name: Amelia Welborn, Ph.D.
- Phone Number: 916-202-5952
- Email: awelborn@mednet.ucla.edu
Study Locations
-
-
California
-
Los Angeles, California, United States, 91754
- Recruiting
- East Los Angeles College
-
Contact:
- Areli Vargas
- Email: VARGASA3@ELAC.EDU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Currently enrolled in the East Los Angeles College
- Either uninsured or covered by California Medicaid
- Own or have private access to internet to complete the assessments and online prevention and therapy programs
- Self-identify as Latinx.
Exclusion Criteria:
- Unable to fully comprehend the consent form, respond adequately to screening questions, or maintain focus or to sit still during assessment
- Diagnosed with disorders requiring more specialized care (e.g., psychotic disorder, severe eating disorder, severe substance use disorder, severe neurological disorder), or marked cognitive impairment
- Currently treated by psychiatrist or psychologist during timeframe that the treatment is offered through STAND and is unwilling to fully transfer care to STAND
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Aim 1
To examine the impact of demographic matching and supervision intensity on treatment engagement, treatment satisfaction, symptoms, and functioning for students receiving digital therapy.
Hypothesis for Main Effect 1: Participants who are matched with Latinx peer coaches will show greater treatment engagement, satisfaction, and improvements in symptom and functioning relative to participants who are not.
Hypothesis for Main Effect 2: Participants assigned to peer coaches in standard supervision will show greater treatment engagement, satisfaction, and improvements in symptom and functioning relative to those assigned to coaches in reduced supervision.
Hypothesis for Interaction Effect: Students assigned to coaches who are demographically matched and receiving standard supervision will show greater treatment engagement, satisfaction, and improvements in symptom and functioning relative to those in all other conditions.
|
At randomization, students will be randomized to a Latinx or non-Latinx coach and will be informed whether or not their coach identifies as Latinx.
Although we are not recruiting coaches or matching coaches with participants based on gender, gender identity or lived experience with mental health problems, we will collect these data from coaches in order to do conduct secondary exploratory analyses examining these variables as predictors or moderators of outcome.
Coaches will be assigned to either standard supervision or reduced supervision, with equal distribution across Latinx vs non-Latinx.
Coaches assigned to standard supervision will receive weekly supervision by a licensed provider consistent with the procedures outlined in the Data and Safety Monitoring Plan for the Signature Project.
Coaches assigned to reduced supervision will attend weekly group supervision, but their session recordings or live sessions will not be reviewed by licensed supervisors or advanced peers and they will not receive personalized feedback about how they are performing in their sessions.
Students will not be informed which supervision condition they have been assigned to in order to maintain high treatment expectancies.
Of note, this design prohibits the coach and supervisors from being blind to participant condition.
|
|
No Intervention: Aim 2
To examine explanatory/intervening variables impacting treatment engagement, treatment satisfaction, symptoms and functioning for students receiving digital therapy.
Hypothesis 2: Evidence of mediation will be observed for the following five explanatory/intervening variables: 1) quality of the relationship between the participant and peer coach, 2) the participants' perception of cultural similarity with their coach, 3) the participants' treatment expectancy and treatment credibility, 4) the participants' perception of their peer coach's cultural competence, and 5) the peer coaches' fidelity to the treatment model.
|
|
|
No Intervention: Aim 3
To examine the cost-effectiveness of providing standard supervision.
Hypothesis 3: Cost-effectiveness analyses will demonstrate that the increased costs incurred by standard supervision relative to reduced supervision will be justified by participants assigned to peer coaches receiving standard supervision experiencing greater improvements in symptoms than those assigned to peer coaches receiving reduced supervision.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Engagement
Time Frame: Up to 24 weeks
|
Indexed by 1) proportion of digital therapy lessons completed and 2) proportion of coaching sessions attended.
|
Up to 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment satisfaction
Time Frame: Up to 24 weeks
|
Healthy Minds Survey: Treatment satisfaction.
(1 item, scored on a 1 to 6 scale).
Higher scores reflect greater treatment satisfaction with the digital therapy program.
|
Up to 24 weeks
|
|
Symptom severity for mental health
Time Frame: Up to 24 weeks
|
Computerized Adaptive Test - Mental Health (CAT-MH).
Symptoms of depression and anxiety are assessed using item response theory (IRT), where a subset of items are selected from a pool of approximately 1000 questions based on participant impairment level.
Higher scores reflect greater symptom severity.
|
Up to 24 weeks
|
|
Baseline social, occupational, and home functioning
Time Frame: Baseline, Weeks 8, 16, and 24
|
Work and Social Adjustment Scale: functioning at work/school, home, social, and leisure activities (5 items, scored on a 0 to 8 scale).
Higher scores reflect better adjustment.
|
Baseline, Weeks 8, 16, and 24
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Amy Sewart, Ph.D., University of California, Los Angeles
- Principal Investigator: Kate Taylor, Ph.D., University of California, Los Angeles
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 26, 2023
Primary Completion (Estimated)
April 30, 2026
Study Completion (Estimated)
April 30, 2026
Study Registration Dates
First Submitted
May 23, 2023
First Submitted That Met QC Criteria
June 9, 2023
First Posted (Actual)
June 18, 2023
Study Record Updates
Last Update Posted (Actual)
July 31, 2025
Last Update Submitted That Met QC Criteria
July 29, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB#22-000218
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Demographic Matching
-
Çankırı Karatekin UniversityCompleted
-
University of WashingtonUnited States Naval Medical Center, San Diego; Madigan Army Medical Center; TriService...UnknownDecision Making | Life ExperiencesUnited States
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedPneumonia | Corona Virus Infection | Acute Respiratory FailureTurkey
-
Memorial Sloan Kettering Cancer CenterTerminated
-
Peking University Third HospitalRecruitingLow Back Pain | Neck Pain | Shoulder PainChina
-
University Hospital, GrenobleRecruiting
-
Hospices Civils de LyonCompletedAdult Patients Developing Optic or Peripheral Neuropathy | While Receiving Tedizolid Therapy Between July 2019 and December 2024France
-
İslam ElagözCompletedNursing Caries | Safety IssuesTurkey